Quant Health
Edit

Quant Health

https://quanthealth.ai/
Last activity: 20.09.2026
Active
Categories: AIBiotechDataAnalyticsHealthTechPharmaSaaS
They have built a unique AI-based clinical trial simulation platform that allows pharmaceutical companies to simulate their upcoming clinical trials in a cloud environment, and test. QuantHealth’s investors include Bessemer Venture Partners, Boston Millennia Partners, Pitango Venture Capital, Atooro, Nina Capital and 4 more.
Mentions
27
Location: Israel
Total raised: $77M

Investors 3

Funding Rounds 3

DateSeriesAmountInvestors
04.08.2026Series B$45MEsplanade ...
08.01.2024-$17M-
31.08.2023Series A$15M-

Mentions in press and media 27

DateTitleDescription
07.08.2026AI Revolutionizes Drug Trials: QuantHealth Secures $45M to Predict SuccessQuantHealth raises $45M in Series B funding. Its AI platform simulates clinical trials. This drastically cuts drug development costs and failure rates. The technology boasts 90% predictive accuracy. It optimizes trial designs for major phar...
05.08.2026HappyRobot Raises $150 Million At $1.2B To Fix Enterprise AI AgentsMost enterprise AI demos look great in a lab. But when you put them on a real phone call with a freight broker, a pricing dispute, and three systems to update, they fall apart. HappyRobot raises $150 million in Series C at a $1.2 billion va...
05.08.2026Volta Raises $300 Million To Tackle Soaring Cost Of Building AI InfrastructureBuilding modern artificial intelligence requires massive amounts of capital. Standard server setups are no longer enough. Today, AI companies must buy thousands of costly chips, secure huge plots of land, and sign giant power contracts just...
04.08.2026Venture Capital & Startup Funding Roundup, August 4, 2026: a16z, Dream Ventures, JPMorgan, Sequoia Capital, SoftBank Vision Fund 2, YC & MoreInvestment today underscored that “big bets” in AI, energy infrastructure and next‑gen security are dominating capital flows. A $1 billion Series B for Valar Atomics and a $1 billion Series D for Base Power – both tied to powering AI worklo...
04.08.2026QuantHealth raises $45M Series B to use AI to predict how patients will respond to therapiesQuantHealth has raised $45 million in Series B funding to scale an ambitious idea: use AI to test clinical trials before drugmakers test them on patients. The round was led by Qumra Capital, with participation from Pitango HealthTech, Sanof...
04.08.2026Zao Asian Grill Receives Investment From Savory FundZao Asian Grill, a Salt Lake City, UT-based provider of a fast-casual Asian-inspired restaurant concept, received an investment from Savory Fund. The amount of the deal was not disclosed. The company intends to use the funds to accelerate n...
04.08.2026Beyond Real-World Trial Iteration: QuantHealth Secures $45M for AI Clinical SimulationWhat You Should Know Tel Aviv-based AI clinical simulation platform QuantHealth closed a $45 million Series B financing round led by Qumra Capital. The round saw participation from major strategic and venture investors, including Sanofi Ven...
04.08.2026Pie Receives Investment from Amex VenturesPie, a Boston, MA-based provider of an AI-powered growth platform for small businesses, received an investment from Amex Ventures. The amount of the deal was not disclosed. The raise brought the total amount in Series A to $19.5M. The compa...
04.08.2026QuantHealth Raises $45 Million Series B Led By Qumra CapitalQuantHealth has raised $45 million in Series B funding to expand its artificial intelligence-powered clinical trial simulation platform. The round was led by Qumra Capital, with participation from Pitango HealthTech, Sanofi Ventures, Artofi...
04.08.2026QuantHealth Raises $45M to Let Pharm Test Clinical Trials with AI Before Spending BillionsDrug development is a gamble. More than 90% of drugs that enter clinical trials fail. Three out of four of those failures are because the drug didn’t work or wasn’t safe. And by the time you find out, you’ve already spent years and hundreds...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In